Our culture of constant innovation fuels our vision: to empower our customers by providing the highest quality, most innovative cancer diagnostic solutions. We are passionate in our pursuit of diagnostic leadership because when we empower pathology professionals, we improve the outlook for patients.
Passionately pursuing their mission to improve the lives of patients afflicted with cancer, the people of Roche Diagnostics discover, develop, and deliver medical diagnostic systems and biopsy based cancer tests that are shaping the future of healthcare. As the leading supplier of cancer diagnostic systems to the pathology market, Roche provides healthcare professionals with a total solution for all critical steps involved in the analysis of tissue biopsies.
Linking the most accurate diagnosis with the most targeted and relevant therapeutic is the essence of Personalised Healthcare. The value of the Personalised Healthcare approach is rooted in positive outcomes for patients – saving lives and improving quality of life. Roche Diagnostics is committed to accelerating the discovery and development of new cancer tests that allow pathologists to analyse patient samples at the molecular level to help determine the best course of therapy for each individual patient. Roche Diagnostics enables this with its global leadership in the development and commercialisation of companion diagnostics for cancer patients.
We offer you our globally trusted solution: our large menu of ready-to-use assays, optimised for use on our proven BenchMark platforms, plus expertise in seven key disease states and a full pipeline of companion diagnostics to meet your needs now and in the future.